Benitec Biopharma
BNTC
BNTC
30 hedge funds and large institutions have $240M invested in Benitec Biopharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 25 → 30 (+5)
48.06% less ownership
Funds ownership: 129.88% → 81.82% (-48%)
Holders
30
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$27.1M | |
| 2 | +$22.1M | |
| 3 | +$14.3M | |
| 4 |
BlackRock
New York
|
+$1.84M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$1.65M |
Top Sellers
| 1 | -$6.61M | |
| 2 | -$551K | |
| 3 | -$508K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$274K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$157K |